ETON |
Eton Pharmaceuticals, Inc. |
Jan 3, 2025 |
6 |
$374K |
4 |
Jan 6, 2025 |
Director |
ETON |
Eton Pharmaceuticals, Inc. |
Jan 3, 2025 |
1 |
$0 |
4 |
Jan 6, 2025 |
Director |
JAZZ |
Jazz Pharmaceuticals plc |
Aug 2, 2024 |
2 |
-$165K |
4 |
Aug 6, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Aug 1, 2024 |
3 |
$0 |
4 |
Aug 5, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jun 5, 2024 |
1 |
$0 |
4 |
Jun 7, 2024 |
Director |
ETON |
Eton Pharmaceuticals, Inc. |
Feb 13, 2024 |
1 |
$0 |
4 |
Feb 15, 2024 |
Director |
JAZZ |
Jazz Pharmaceuticals plc |
Aug 11, 2023 |
2 |
-$171K |
4 |
Aug 15, 2023 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jun 7, 2023 |
2 |
$0 |
4 |
Jun 9, 2023 |
Director |
ETON |
Eton Pharmaceuticals, Inc. |
Mar 3, 2023 |
1 |
$0 |
4 |
Mar 3, 2023 |
Director |
APTX |
Aptinyx Inc. |
Jan 3, 2023 |
1 |
$0 |
4 |
Jan 5, 2023 |
EXECUTIVE CHAIRMAN OF THE BOD, Director |
JAZZ |
Jazz Pharmaceuticals plc |
Aug 5, 2022 |
5 |
-$971K |
4 |
Aug 9, 2022 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jun 14, 2022 |
1 |
$0 |
4 |
Jun 16, 2022 |
Director |
ETON |
Eton Pharmaceuticals, Inc. |
Feb 7, 2022 |
1 |
$0 |
4 |
Feb 28, 2022 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jan 4, 2022 |
2 |
$0 |
4 |
Jan 6, 2022 |
Director |
APTX |
Aptinyx Inc. |
Dec 6, 2021 |
1 |
$223K |
4 |
Dec 8, 2021 |
CEO, Director |
APTX |
Aptinyx Inc. |
Dec 2, 2021 |
1 |
$0 |
4 |
Dec 7, 2021 |
CEO, Director |
JAZZ |
Jazz Pharmaceuticals plc |
Aug 6, 2021 |
1 |
-$193K |
4 |
Aug 10, 2021 |
Director |
JAZZ |
Jazz Pharmaceuticals plc |
Jul 29, 2021 |
1 |
$0 |
4 |
Aug 2, 2021 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jun 10, 2021 |
1 |
$0 |
4 |
Jun 14, 2021 |
Director |
APTX |
Aptinyx Inc. |
May 17, 2021 |
3 |
-$322K |
4/A |
May 20, 2021 |
CEO, Director |